activity
20202024
most citedUnderstanding the role of phenotypic switching in cancer drug resistance

79 citations · 93 across the 3 of their papers we have counts for

collaborators
Showing q-bio.PEShow all

6 papers · 1 filter

q-bio.PE2026

Branching-Time Signatures of Growth Regime in Tumor Birth-Death Models

Meng Wang, Zhangchi Weng, Jasmine Foo +1

Tumor evolution is shaped by cell division, cell death, competition, and constraints imposed by the local microenvironment. Because these dynamics are usually not observed directly…

q-bio.PE2024

Optimal dosing of anti-cancer treatment under drug-induced plasticity

Einar Bjarki Gunnarsson, Benedikt Vilji Magnússon, Jasmine Foo

While cancer has traditionally been considered a genetic disease, mounting evidence indicates an important role for non-genetic (epigenetic) mechanisms. Common anti-cancer drugs ha…

q-bio.PE2024

A statistical framework for detecting therapy-induced resistance from drug screens

Chenyu Wu, Einar Bjarki Gunnarsson, Jasmine Foo +1

Resistance to therapy remains a significant challenge in cancer treatment, often due to the presence of a stem-like cell population that drives tumor recurrence post-treatment. Mor…

q-bio.PE2022

Dynamics of advantageous mutant spread in spatial death-birth and birth-death Moran models

Jasmine Foo, Einar Bjarki Gunnarsson, Kevin Leder +1

The spread of an advantageous mutation through a population is of fundamental interest in population genetics. While the classical Moran model is formulated for a well-mixed popula…

q-bio.PE2021

Exact site frequency spectra of neutrally evolving tumors: a transition between power laws reveals a signature of cell viability

Einar Bjarki Gunnarsson, Kevin Leder, Jasmine Foo

The site frequency spectrum (SFS) is a popular summary statistic of genomic data. While the SFS of a constant-sized population undergoing neutral mutations has been extensively stu…

q-bio.PE202079 cited

Understanding the role of phenotypic switching in cancer drug resistance

Einar Bjarki Gunnarsson, Subhajyoti De, Kevin Leder +1

The emergence of acquired drug resistance in cancer represents a major barrier to treatment success. While research has traditionally focused on genetic sources of resistance, rece…